The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter,...
Keep Reading →
December 16 - Hedge Funds, News - Comments
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (...
Keep Reading →
October 12 - Hedge Funds, News - Comments
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings...
Keep Reading →
August 4 - Hedge Funds, News - Comments
In this article we will check out the progression of hedge fund sentiment towards ImmunoGen, Inc. (NASDAQ:IMGN) and determine whether it is a good investment...
Keep Reading →
June 23 - Hedge Funds, News - Comments
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November. Among them, Facebook...
Keep Reading →
December 14 - Hedge Funds, News - Comments
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the...
Keep Reading →
November 7 - Hedge Funds, News - Comments
Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by nearly 9 percentage points since the end of the third quarter of 2018 as investors worried...
Keep Reading →
June 27 - Hedge Funds, News - Comments
The elite funds run by legendary investors such as David Tepper and Dan Loeb make hundreds of millions of dollars for themselves and their investors by...
Keep Reading →
May 5 - Hedge Funds, News - Comments
Column: Hedge Funds Bet Cautiously on Even Higher Oil Prices (Reuters) LONDON (Reuters) – Hedge funds added more bullish positions in crude and...
Keep Reading →
February 25 - Hedge Funds, Insider Trading - Comments
Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings. The 13F...
Keep Reading →
December 17 - Hedge Funds, News - Comments
Steven Cohen Wins Dismissal of $8 billion Fairfax Short-selling Lawsuit (Reuters) (Reuters) – The billionaire Steven A. Cohen has won the dismissal...
Keep Reading →
April 3 - Hedge Funds, Insider Trading - Comments
Trading ‘BOON’ Pickens: Oil Tycoon’s Spinoff Fund Seeks Listing (Bloomberg) Legendary oil tycoon T. Boone Pickens has closed his hedge fund,...
Keep Reading →
February 28 - Hedge Funds, Insider Trading - Comments
Electronic Arts Inc. (NASDAQ:EA) (MarketWatch) The poor performance of Electronic Arts Inc.’s “Star Wars Battlefront 2” was in the spotlight on...
Keep Reading →
January 31 - Market Movers, News - Comments
1. U.S. Stock Market: “Stocks rose on Wall Street on Thursday, capping a wave of declines in major world equity markets triggered by uncertainty...
Keep Reading →
May 18 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
1. U.S. Stock Market: “The S&P 500 and the Nasdaq Composite hit fresh intraday records on Monday as a jump in oil prices to a two-week high...
Keep Reading →
May 15 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
1. US Stock Market: “U.S. equities traded mixed on Wednesday, with IBM sending the Dow Jones industrial average lower and Morgan Stanley leading...
Keep Reading →
April 19 - Commodities, Gold, Market Movers, News, Tech - Comments
1. US Stock Market: “Stocks fell on Thursday after the U.S. dropped “the mother of all bombs” in Afghanistan while bank stocks dropped...
Keep Reading →
April 13 - Commodities, Gold, Market Movers, News, Tech - Comments
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment...
Keep Reading →
December 7 - Hedge Funds, News - Comments
The three major index futures and crude are once again in the red on Tuesday amid Brexit fears. If Britain leaves the EU, there could be an unexpected...
Keep Reading →
June 14 - Market Movers, News, Tech - Comments
The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by...
Keep Reading →
November 25 - Hedge Funds, News - Comments
ImmunoGen Inc. (NASDAQ:IMGN), Vipshop Holdings Limited (NYSE:VIPS), Urban Outfitters Inc. (NASDAQ:URBN), and TerraForm Power Inc. (NASDAQ:TERP) ...
Keep Reading →
November 16 - Earnings Report, Market Movers, News - Comments
Is Nektar Therapeutics (NASDAQ:NKTR) a good investment? Now, according to many of your peers, hedge funds are assumed to be useless, outdated investment...
Keep Reading →
September 17 - News - Comments
To many investors, hedge funds are assumed to be bloated, outdated investment tools of a forgotten age. Although there are In excess of 8,000 hedge funds...
Keep Reading →
September 11 - News - Comments
Is Viropharma Inc (NASDAQ:VPHM) a good investment? If you were to ask many traders, hedge funds are seen as useless, old investment vehicles of an era...
Keep Reading →
August 28 - News - Comments
Who’s crazy about Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)? If you were to ask many market players, hedge funds are seen as useless, outdated...
Keep Reading →
August 22 - News - Comments
Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) the right investment to pursue these days? Hedge funds are taking a bullish view. The number of bullish...
Keep Reading →
August 6 - News - Comments
Cancer is the target of a number of different biotech companies. Out of this lot, I consider Seattle Genetics, Inc. (NASDAQ:SGEN) to be one of the star...
Keep Reading →
August 6 - News - Comments
Today, cancer is the second leading cause of death in the United States, accounting for nearly a quarter of all deaths in the country. 1.7 million new...
Keep Reading →
July 3 - News - Comments
Anticancer drugs typically damage normal cells as well as cancer cells. Using a breakthrough technology, a midsize biotech company is developing a process...
Keep Reading →
July 2 - News - Comments
The cancer world has been abuzz after an exciting ASCO conference. Bristol Myers Squibb Co. (NYSE:BMY) presented really promising updates for its PD-...
Keep Reading →
June 14 - News - Comments
Nektar Therapeutics (NASDAQ:NKTR) was in 8 hedge funds’ portfolio at the end of March. NKTR has experienced a decrease in support from the world...
Keep Reading →
June 12 - News - Comments
There’s never a shortage of losers in the stock market. Let’s take a closer look at five of this past week’s biggest sinkers. Company...
Keep Reading →
June 10 - News - Comments
Is ImmunoGen, Inc. (NASDAQ:IMGN) an excellent investment now? Prominent investors are in a bearish mood. The number of bullish hedge fund bets stayed...
Keep Reading →
June 4 - News - Comments
Over the past three months, we’ve taken a deep dive into the 12 cancer types most likely to be diagnosed in the U.S. this year according to the...
Keep Reading →
June 3 - News - Comments
I admit to not being a big fan of many of her movies — possibly the only man on the planet who will admit so — but there’s little denying...
Keep Reading →
May 16 - News - Comments
ImmunoGen, Inc. (NASDAQ:IMGN) investors should pay attention to a decrease in hedge fund interest recently. At the moment, there are dozens of methods...
Keep Reading →
April 19 - News - Comments
A lot has been written this week — at The Fool and elsewhere — about Sarepta Therapeutics Inc (NASDAQ:SRPT)‘ update on its meeting...
Keep Reading →
April 18 - News - Comments
Acorda Therapeutics Inc (NASDAQ:ACOR) was in 10 hedge funds’ portfolio at the end of the fourth quarter of 2012. ACOR investors should pay attention...
Keep Reading →
April 12 - News - Comments
The process of developing a drug from start to finish is incredibly arduous, usually involves around $1 billion in costs, and can take upwards of a decade...
Keep Reading →
April 12 - News - Comments
As I noted two weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing...
Keep Reading →
March 12 - News - Comments
As we’ve learned in recent years, getting an approval from the Food and Drug Administration is only half the battle. Successfully commercializing...
Keep Reading →
February 25 - News - Comments
With the SPDR S&P Biotech Index up 25% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the...
Keep Reading →
February 23 - News - Comments